Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
The Effect of Transcription Factor MYB14 on Defense Mechanisms in Vitis quinquangularis-Pingyi.
Luo Y, Wang Q, Bai R, Li R, Chen L, Xu Y, Zhang M, Duan D. Luo Y, et al. Int J Mol Sci. 2020 Jan 21;21(3):706. doi: 10.3390/ijms21030706. Int J Mol Sci. 2020. PMID: 31973146 Free PMC article.
In the current study, we identified a transcription factor, MYB14, from Chinese wild grape, Vitis quinquangularis-Pingyi (V. quinquangularis-PY), which could enhance the main stilbene contents and expression of stilbene biosynthesis genes (StSy/RS) by overexpression of VqM …
In the current study, we identified a transcription factor, MYB14, from Chinese wild grape, Vitis quinquangularis-Pingyi (V. quinquan …
Telerobot-assisted laparoscopic adrenalectomy: feasibility study.
Li J, Jiao W, Yuan H, Feng W, Ding X, Yin X, Zhang L, Lv W, Ma L, Sun L, Feng R, Qin J, Zhang X, Gou C, Wang S, Yu Z, Wei B, Luo L, Xie F, Chang Y, Wang Y, Giulianotti PC, Dong Q, Niu H. Li J, et al. Br J Surg. 2022 Dec 13;110(1):6-9. doi: 10.1093/bjs/znac279. Br J Surg. 2022. PMID: 35997257 No abstract available.
The XINDI Study: A Randomized Phase III Clinical Trial Evaluating the Efficacy and Safety of Safinamide as Add-On Therapy to Levodopa in Chinese Patients with Parkinson's Disease with Motor Fluctuations.
Wei Q, Tan Y, Xu P, Tao E, Lu Z, Pan X, Wang B, Liu C, Dong X, Tian Y, Sun X, Cattaneo C, Chen S, Shang H; XINDI Study Investigators Group. Wei Q, et al. CNS Drugs. 2022 Nov;36(11):1217-1227. doi: 10.1007/s40263-022-00958-6. Epub 2022 Nov 8. CNS Drugs. 2022. PMID: 36346534 Free PMC article. Clinical Trial.